CI3 Cluster for Individualized Immune Intervention: “Clinical Development of Transglutaminase-Inhibitors for the Treatment of Celiac Disease” (phase 2)
Laufzeit: 01.01.2015 - 31.12.2017
Kurzfassung
CI3 Cluster for Individualized Immune Intervention: “Clinical Development of Transglutaminase-Inhibitors for the Treatment of Celiac Disease” (phase 2)
